Windtree Delisted: Crypto Gamble Leads to Nasdaq Demise

Windtree Therapeutics has been removed from the Nasdaq stock exchange following a plunge in share prices below the required minimum trading price. This marks a dramatic end for the biotech firm, which attempted a risky shift toward cryptocurrencies and ultimately failed to escape financial instability. Just weeks after committing to invest up to $700 million in Binance’s BNB token, Windtree shares plummeted by nearly 80% on August 21st, leaving the company vulnerable to delisting. This raises questions about whether this gamble of a crypto-based strategy was either a desperate attempt or an elaborate charade.